Skip to main content

Vivoryon Therapeutics NV (VVY.AS) Stock Price and Company Information, 2024

Vivoryon Therapeutics NV

VVY.AS

Exchange: AS
Currency Euro
ISIN: DE0007921835
LEI: 3912004AMB0KGZXZYJ15
Primary Ticker: PB9.XETRA
Fiscal Year End: December
Sector: Healthcare
Industry: Biotechnology
Gic Sector: Health Care
Gic Group: Pharmaceuticals, Biotechnology & Life Sciences
Gic Industry: Biotechnology
Gic Sub Industry: Biotechnology
Description: Vivoryon Therapeutics N.V., a clinical stage biopharmaceutical company, engages in the research, development, and commercialize small molecule-based medicines. Its pipeline products target toxic pyroglutamate-Abeta (p Glu-Abeta), which inhibits the production of p Glu-Abeta. The company's lead product candidate is PQ912, a nanomolar QPCT inhibitor that has completed Phase I Ib clinical trials for use in the treatment of Alzheimer's disease. In addition, the company is developing a monoclonal antibody PBD-C06 is for N3p E-Abeta. Vivoryon Therapeutics N.V. has a collaboration agreement with Nordic Bioscience for the clinical development of PQ912 for Alzheimer's disease; and research collaboration with the Fraunhofer Institute for cell therapy and immunology, as well as a strategic regional licensing partnership with Simcere Pharmaceutical Group Ltd. to develop and commercialize medicines targeting the neurotoxic amyloid species N3p E (p Glu-Abeta) to treat Alzheimer's disease. Vivoryon Therapeutics N.V. was founded in 1997 and is headquartered in Halle, Germany.
Address: Weinbergweg 22, Halle, Germany, 06120
Website: https://www.vivoryon.com
Full Time Employees: 15
Updated On: 2024-11-05

Highlights

Market Capitalization: 59432304
Market Capitalization Mln: 59.43
EBITDA: -31265000
Wall Street Target Price: 17.1
Book Value: 0.53
Earnings Share: -1.2
EPS Estimate Current Year: -1.01
EPS Estimate Next Year: -0.75
Most Recent Quarter: 2023-06-30
Operating Margin TTM: 8.66
Return On Assets TTM: -0.62
Return On Equity TTM: -1.12
Revenue TTM: -3620000
Revenue Per Share TTM: -0.14
Gross Profit TTM: 9195000
Diluted Eps TTM: -1.2

Valuation

Price Sales TTM: 26.59
Price Book MRQ: 4.30
Enterprise Value: 44878328
Enterprise Value Revenue: 28.96
Enterprise Value Ebitda: -24.25

Technicals

Beta: 1.88
52 Week High: 9.93
52 Week Low: 0.41
50 Day MA: 2.25
200 Day MA: 2.69

Earnings

Report Date: 2024-01-08
Date: 2023-12-31
Before After Market: After Market
Currency: EUR
Eps Estimate: -0.52
Eps Difference: 0.52
Surprise Percent: 10
Report Date: 2023-12-06
Date: 2023-09-30
Before After Market: After Market
Currency: EUR
Report Date: 2023-09-07
Date: 2023-06-30
Before After Market: Before Market
Currency: EUR
Eps Estimate: -0.6
Eps Difference: 0.6
Surprise Percent: 10
Report Date: 2023-04-19
Date: 2023-03-31
Before After Market: After Market
Currency: EUR
Eps Actual: -1.28
Eps Estimate: -0.61
Eps Difference: -0.67
Surprise Percent: -109.83
Report Date: 2023-03-30
Date: 2022-12-31
Currency: EUR
Eps Estimate: -0.61
Eps Difference: 0.61
Surprise Percent: 10
Report Date: 2022-11-22
Date: 2022-09-30
Before After Market: After Market
Currency: EUR
Report Date: 2022-09-30
Date: 2022-06-30
Before After Market: After Market
Currency: EUR
Eps Actual: -0.6
Eps Estimate: -0.06
Eps Difference: -0.54
Surprise Percent: -90
Report Date: 2022-04-28
Date: 2022-03-31
Currency: EUR
Eps Actual: -0.05
Eps Estimate: -0.41
Eps Difference: 0.36
Surprise Percent: 87.80
Report Date: 2021-11-04
Date: 2021-09-30
Currency: EUR
Eps Actual: -0.58
Report Date: 2021-09-21
Date: 2021-06-30
Currency: EUR
Eps Actual: -0.58
Eps Estimate: -0.58
Report Date: 2021-04-30
Date: 2021-03-31
Currency: EUR
Eps Actual: -0.45
Eps Estimate: -0.42
Eps Difference: -0.03
Surprise Percent: -7.14
Report Date: 2020-11-26
Date: 2020-09-30
Currency: EUR
Eps Actual: -0.38
Eps Difference: -0.38
Report Date: 2020-08-27
Date: 2020-06-30
Currency: EUR
Eps Actual: -0.38
Eps Estimate: -0.39
Eps Difference: 0.01
Surprise Percent: 2.56
Report Date: 2020-05-14
Date: 2020-03-31
Currency: EUR
Eps Actual: -0.57
Eps Difference: -0.57
Report Date: 2020-03-26
Date: 2019-12-31
Currency: EUR
Eps Actual: 0.3
Eps Estimate: -0.26
Eps Difference: 0.56
Surprise Percent: 215.38
Report Date: 2019-11-28
Date: 2019-09-30
Currency: EUR
Eps Actual: -0.3
Eps Difference: -0.3
Report Date: 2019-08-29
Date: 2019-06-30
Currency: EUR
Eps Actual: -0.31
Eps Estimate: -0.35
Eps Difference: 0.04
Surprise Percent: 11.42
Report Date: 2019-05-16
Date: 2019-03-31
Currency: EUR
Eps Actual: -0.43
Eps Difference: -0.43
Report Date: 2019-03-28
Date: 2018-12-31
Currency: EUR
Eps Actual: -0.43
Eps Estimate: -0.39
Eps Difference: -0.04
Surprise Percent: -10.25
Report Date: 2018-11-29
Date: 2018-09-30
Currency: EUR
Eps Actual: -0.43
Eps Difference: -0.43
Report Date: 2018-08-30
Date: 2018-06-30
Currency: EUR
Eps Actual: -0.5
Eps Difference: -0.5
Report Date: 2018-04-03
Date: 2018-03-31
Currency: EUR
Eps Actual: -0.45
Eps Estimate: -0.73
Eps Difference: 0.28
Surprise Percent: 38.35
Report Date: 2017-08-31
Date: 2017-06-30
Currency: EUR
Eps Actual: -0.53
Eps Difference: -0.53
Report Date: 2017-03-30
Date: 2016-12-31
Currency: EUR
Eps Actual: -1.01
Eps Estimate: -1.1
Eps Difference: 0.09
Surprise Percent: 8.18
Report Date: 2016-11-10
Date: 2016-09-30
Currency: EUR
Date: 2025-12-31
Period: +1y
Growth: 0.25
Earnings Estimate Avg: -0.75
Earnings Estimate Low: -0.82
Earnings Estimate High: -0.63
Earnings Estimate Year Ago Eps: -1.01
Earnings Estimate Number Of Analysts: 3.00
Earnings Estimate Growth: 0.25
Revenue Estimate Number Of Analysts: 3.00
Eps Trend Current: -0.75
Eps Trend7days Ago: -0.72
Eps Trend30days Ago: -0.72
Eps Trend60days Ago: -0.67
Eps Trend90days Ago: -0.93
Eps Revisions Down Last30days: 1.00
Date: 2024-12-31
Growth: 0.09
Earnings Estimate Avg: -1.01
Earnings Estimate Low: -1.10
Earnings Estimate High: -0.88
Earnings Estimate Year Ago Eps: -1.12
Earnings Estimate Number Of Analysts: 3.00
Earnings Estimate Growth: 0.09
Revenue Estimate Number Of Analysts: 3.00
Eps Trend Current: -1.01
Eps Trend7days Ago: -0.97
Eps Trend30days Ago: -0.97
Eps Trend60days Ago: -0.79
Eps Trend90days Ago: -0.80
Eps Revisions Up Last7days: 1.00
Eps Revisions Up Last30days: 1.00
Date: 2024-09-30
Period: +1q
Date: 2024-06-30
Date: 2024-03-31
Date: 2023-12-31
Growth: 0.24
Earnings Estimate Avg: -0.97
Earnings Estimate Low: -1.10
Earnings Estimate High: -0.78
Earnings Estimate Year Ago Eps: -1.28
Earnings Estimate Number Of Analysts: 5.00
Earnings Estimate Growth: 0.24
Revenue Estimate Number Of Analysts: 4.00
Eps Trend Current: -0.97
Eps Trend7days Ago: -0.97
Eps Trend30days Ago: -0.97
Eps Trend60days Ago: -0.97
Eps Trend90days Ago: -0.90
Date: 2023-09-30
Date: 2023-06-30
Date: 2023-03-31
Date: 2022-12-31
Growth: -0.47
Earnings Estimate Avg: -0.93
Earnings Estimate Low: -1.25
Earnings Estimate High: -0.50
Earnings Estimate Year Ago Eps: -0.63
Earnings Estimate Number Of Analysts: 4.00
Earnings Estimate Growth: -0.47
Revenue Estimate Number Of Analysts: 3.00
Eps Trend Current: -0.93
Eps Trend7days Ago: -0.93
Eps Trend30days Ago: -0.93
Eps Trend60days Ago: -0.93
Eps Trend90days Ago: -0.93
Date: 2022-09-30
Date: 2022-06-30
Date: 2019-12-31
Period: +1y
Revenue Estimate Avg: 740000.00
Revenue Estimate High: 2210000.00
Revenue Estimate Number Of Analysts: 3.00
Revenue Estimate Growth: 3.11
Eps Trend7days Ago: -0.83
Eps Trend30days Ago: -0.83
Eps Trend60days Ago: -0.83
Eps Trend90days Ago: -0.83
Eps Revisions Up Last30days: 1.00
Date: 2019-06-30
Period: +1q
Revenue Estimate Avg: 180000.00
Revenue Estimate High: 550000.00
Revenue Estimate Number Of Analysts: 3.00
Date: 2019-03-31
Revenue Estimate Avg: 180000.00
Revenue Estimate High: 550000.00
Revenue Estimate Number Of Analysts: 3.00
Date: 2018-12-31
Revenue Estimate Avg: 180000.00
Revenue Estimate High: 550000.00
Revenue Estimate Number Of Analysts: 3.00
Eps Trend7days Ago: -0.91
Eps Trend30days Ago: -0.91
Eps Trend60days Ago: -0.91
Eps Trend90days Ago: -0.91
Eps Revisions Up Last30days: 1.00
Date: 2023-12-31
Eps Actual: -1.2
Date: 2022-12-31
Eps Actual: -3.5
Date: 2019-12-31
Eps Actual: -0.7
Date: 2018-12-31
Eps Actual: -2.3
Date: 2016-12-31
Eps Actual: -1.0